Not Tagged
genmab
['lymphoma', 'dlbcl', 'genmab']
today we are presenting new data at #asco23 in various types of #lymphoma in high-risk patient populations including #dlbcl and #lbcl. tune in live today: 
We are a leader in harnessing the power of human antibodies and our purpose is to improve the lives of people with cancer | Disclaimer https://t.co/E8NokG2tvL